Kathleen R. Blazer, Ed.D. - Publications

Affiliations: 
2010 University of California, Los Angeles, Los Angeles, CA 
Area:
Health Education, Continuing Education, Adult and Continuing Education, Technology of Education

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Capasso A, Nehoray B, Gorman N, Quinn EA, Bucio D, Blazer KR. Genetic counselors' and community clinicians' implementation and perceived barriers to informed consent during pre-test counseling for hereditary cancer risk. Journal of Genetic Counseling. PMID 38480478 DOI: 10.1002/jgc4.1887  0.35
2022 Nehoray B, Slavin TP, Sun CL, Hurley K, King E, Tsang KK, Cervantes A, Mokhnatkin JV, Sand S, Mejia R, Reb A, Samimi G, Gray S, Blazer KR, Weitzel JN. Cross-sectional clinical cancer genomics community of practice survey analysis of provider attitudes and beliefs regarding the use of deceased family member tissue to guide living family member genetic cancer risk assessment. Journal of Genetic Counseling. PMID 35617031 DOI: 10.1002/jgc4.1587  0.388
2021 Blazer KR, Chavarri-Guerra Y, Villarreal Garza C, Nehoray B, Mohar A, Daneri-Navarro A, Del Toro A, Aguilar D, Arteaga J, Álvarez RM, Mejia R, Herzog J, Castillo D, Fernandez M, Weitzel JN. Development and Pilot Implementation of the Genomic Risk Assessment for Cancer Implementation and Sustainment (GRACIAS) Intervention in Mexico. Jco Global Oncology. 7: 992-1002. PMID 34181458 DOI: 10.1200/GO.20.00587  0.441
2021 Weitzel JN, Kidd J, Bernhisel R, Shehayeb S, Frankel P, Blazer KR, Turco D, Nehoray B, McGreevy K, Svirsky K, Brown K, Gardiner A, Daly M, Hughes E, Cummings S, et al. Multigene assessment of genetic risk for women for two or more breast cancers. Breast Cancer Research and Treatment. PMID 33826040 DOI: 10.1007/s10549-021-06201-y  0.41
2020 Guerra YC, Rodríguez-Faure A, Guerra LMB, Olivares JLR, Arteaga J, Castillo D, Mejia R, Herzog J, Blazer KR, Weitzel JN. Communication of genetic testing results and cascade testing among Mexican carriers of cancer-associated variants and their families. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E13541  0.472
2019 Chavarri-Guerra Y, Hendricks CB, Brown S, Marcum C, Hander M, Segota ZE, Hake C, Sand S, Slavin TP, Hurria A, Soto-Perez-de-Celis E, Nehoray B, Blankstein KB, Blazer KR, Weitzel JN, et al. The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients. Journal of the American Geriatrics Society. PMID 31012959 DOI: 10.1111/Jgs.15937  0.508
2019 Aguilar y Méndez D, Weitzel JN, Blazer KR, Castillo D, Herzog J, Marrufo JCA, García-García M, Mesa-Chavez F, Miaja M, Cardona-Huerta S, Villarreal-Garza C. Enhancing access to genetic cancer risk assessment (GCRA) in Monterrey, Mexico: The beginning of a prevention program. Journal of Clinical Oncology. 37: e13150-e13150. DOI: 10.1200/Jco.2019.37.15_Suppl.E13150  0.556
2019 Guerra YC, Weitzel JN, Blazer KR, Slavin TP, Mejia R, Sand S, Castillo D, Herzog J, Villarreal-Garza C, Mohar A, Rodriguez Y, Alferez APM, Hake CR, Cescon T, Bobolis K, et al. Germline mutation profile among Hispanic women with epithelial ovarian cancer (EOC). Journal of Clinical Oncology. 37: 1584-1584. DOI: 10.1200/Jco.2019.37.15_Suppl.1584  0.463
2018 Solomon I, Rybak C, Van Tongeren L, Kuzmich L, Blazer K, Nehoray B, Niell-Swiller M, Bray S, Bray TH, Hurley K, Weitzel JN, Slavin TP. Experience Gained from the Development and Execution of a Multidisciplinary Multi-syndrome Hereditary Colon Cancer Family Conference. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. PMID 30259397 DOI: 10.1007/S13187-018-1430-9  0.528
2018 Slavin TP, Van Tongeren LR, Behrendt CE, Solomon I, Rybak C, Nehoray B, Kuzmich L, Niell-Swiller M, Blazer KR, Tao S, Yang K, Culver JO, Sand S, Castillo D, Herzog J, et al. Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry. Journal of the National Cancer Institute. PMID 29618041 DOI: 10.1093/Jnci/Djy027  0.42
2018 Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, ... ... Blazer KR, et al. Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations. Human Mutation. PMID 29446198 DOI: 10.1002/Humu.23406  0.39
2018 West AH, Blazer KR, Stoll J, Jones M, Weipert CM, Nielsen SM, Kupfer SS, Weitzel JN, Olopade OI. Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk. Familial Cancer. PMID 29445900 DOI: 10.1007/S10689-018-0070-X  0.566
2018 Chavarri-Guerra Y, Yang K, Komenaka I, Brown S, Valero ADT, Alférez PM, Duncan P, Rodríguez Y, Ganschow P, Campbell-Fontaine A, Unzeitig G, Horcasitas D, Feldman N, Slavin T, Nehoray B, ... ... Blazer K, et al. Abstract P6-09-05: Factors associated with the uptake of risk-reducing surgeries among Hispanic women at high risk of breast and ovarian cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P6-09-05  0.491
2017 Weitzel JN, Chao EC, Nehoray B, Van Tongeren LR, LaDuca H, Blazer KR, Slavin T, Facmg DABMD, Pesaran T, Rybak C, Solomon I, Niell-Swiller M, Dolinsky JS, Castillo D, Elliott A, et al. Somatic TP53 variants frequently confound germ-line testing results. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 29189820 DOI: 10.1038/Gim.2017.196  0.375
2017 Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, ... ... Blazer KR, et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics. PMID 29058716 DOI: 10.1038/Ng.3785  0.515
2017 Slavin T, Neuhausen SL, Rybak C, Solomon I, Nehoray B, Blazer K, Niell-Swiller M, Adamson AW, Yuan YC, Yang K, Sand S, Castillo D, Herzog J, Wu X, Tao S, et al. Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network. Cancer Genetics. 216: 111-119. PMID 29025585 DOI: 10.1016/J.Cancergen.2017.08.001  0.498
2017 Slavin TP, Neuhausen SL, Nehoray B, Niell-Swiller M, Solomon I, Rybak C, Blazer K, Adamson A, Yang K, Sand S, Guerrero-Llamas N, Castillo D, Herzog J, Wu X, Tao S, et al. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Familial Cancer. PMID 28687971 DOI: 10.1007/S10689-017-0019-5  0.552
2017 Chavarri-Guerra Y, Blazer KR, Weitzel JN. Genetic Cancer Risk Assessment for Breast Cancer in Latin America. Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion. 69: 94-102. PMID 28453507 DOI: 10.24875/Ric.17002195  0.58
2017 Chavarri Guerra Y, Sand S, Brown S, Hendricks CB, Hander M, Weeman K, Nadesan S, Segota ZE, Cheng HHW, Hurria A, Soto Perez De Celis E, Nehoray B, Kuzmich L, Solomon I, Rybak C, ... Blazer KR, et al. Germline cancer susceptibility mutations in older women with breast cancer (BC). Journal of Clinical Oncology. 35: e13030-e13030. DOI: 10.1200/Jco.2017.35.15_Suppl.E13030  0.443
2017 Slavin TP, Gray SW, Tongeren LRV, Solomon I, Rybak C, Nehoray B, Kuzmich L, Niell-Swiller M, Blazer KR, Yang K, Culver J, Sand S, Castillo D, Herzog J, Weitzel JN. Abstract 4273: Variant reclassifications in hereditary cancer genetics and their implications for clinical care Cancer Research. 77: 4273-4273. DOI: 10.1158/1538-7445.Am2017-4273  0.554
2016 Slavin TP, Blazer KR, Weitzel JN. When Clinical Care Depends on the Answer: The Challenges of Assessing Germline Cancer Gene Variants. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 4061-4063. PMID 27863196 DOI: 10.1200/Jco.2016.69.7151  0.438
2016 Blazer KR, Slavin T, Weitzel JN. Increased Reach of Genetic Cancer Risk Assessment as a Tool for Precision Management of Hereditary Breast Cancer. Jama Oncology. PMID 26869327 DOI: 10.1001/Jamaoncol.2015.5975  0.608
2016 Chavez TA, Nehoray B, Ricker C, Blazer KR, Sand S, Ashing KT, Cordova J, Uman G, Yang K, Feldman N, Weitzel JN. Abstract A50: Differences in perceived personal control among Latina women undergoing genetic cancer risk assessment for hereditary breast and ovarian cancer Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-A50  0.496
2016 Weitzel J, Blazer K, Nehoray B, Kidd J, Slavin T, Solomon I, Niell-Swiller M, Rybak C, Saam J, Lancaster J. Abstract PD7-02: Multiplex Identification of genetic etiologies among women with bilateral breast cancer using a 25-gene hereditary cancer panel Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-Pd7-02  0.567
2016 Weitzel JN, Villarreal-Garza C, Blazer KR, Herzog J, Castillo D, Chavez T, Gallardo-Alvarado L, Wegman T, Alvarez R, Unger K, Fernandez M, Toro-Valero Ad, Navarro AD, Meneses A, Montalvo LH, et al. Abstract 3465: Dissemination and implementation of genomic cancer risk assessment in Latin America via innovative pairing of clinical training and genomic tools Cancer Research. 76: 3465-3465. DOI: 10.1158/1538-7445.Am2016-3465  0.475
2016 Slavin TP, Yang K, Sand S, Chavez T, Castillo D, Herzog J, Solomon I, Rybak C, Niell-Swiller M, Nehoray B, Adamson A, Blazer K, Neuhausen S, Weitzel J. Abstract 2551: Identifying hereditary gastric cancer predisposition in the clinical cancer genomics community research network Cancer Research. 76: 2551-2551. DOI: 10.1158/1538-7445.Am2016-2551  0.535
2015 Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN. Corrigendum: Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management. Frontiers in Oncology. 5: 271. PMID 26697406 DOI: 10.3389/fonc.2015.00271  0.3
2015 Blazer KR, Nehoray B, Solomon I, Niell-Swiller M, Culver JO, Uman GC, Weitzel JN. Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings. Genetic Testing and Molecular Biomarkers. 19: 657-65. PMID 26539620 DOI: 10.1089/Gtmb.2015.0061  0.487
2015 Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN. Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management. Frontiers in Oncology. 5: 208. PMID 26484312 DOI: 10.3389/Fonc.2015.00208  0.531
2015 Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard J, Soucy P, Eeles RA, Easton DF, Hamann U, Wilkening S, Chen B, Rookus MA, Schmidt MK, van der Baan FH, ... ... Blazer KR, et al. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 308-16. PMID 25336561 DOI: 10.1158/1055-9965.Epi-14-0532  0.547
2015 Villarreal-Garza C, Alvarez-Gómez RM, Pérez-Plasencia C, Herrera LA, Herzog J, Castillo D, Mohar A, Castro C, Gallardo LN, Gallardo D, Santibáñez M, Blazer KR, Weitzel JN. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. Cancer. 121: 372-8. PMID 25236687 DOI: 10.1002/Cncr.29058  0.533
2015 Weitzel JN, Blazer KR, Nehoray B, Kidd J, Slavin TP, Solomon I, Niell-Swiller M, Rybak C, Saam J. Assessment of the clinical presentation of patients with at least two deleterious mutations on multi-gene panel testing. Journal of Clinical Oncology. 33: 1514-1514. DOI: 10.1200/Jco.2015.33.15_Suppl.1514  0.47
2015 Chavez T, Nehoray B, Obregon-Tito A, Ricker C, Solomon I, Niell-Swiller M, Ryback C, Abugattas JE, Sullcahuaman Y, Noriega MF, Orduz AI, Melo JM, Chaves A, Gallardo L, Villarreal C, ... ... Blazer KR, et al. Abstract A36: Exploring the climate, barriers, and possible approaches to implementing genetic cancer risk assessment in Latin America: A roundtable discussion Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-A36  0.5
2015 Clague J, Villarreal-Garza C, Navarro AD, Obregon-Tito AJ, Sand S, Chavez TA, Nehoray B, Robinson L, Gallardo L, Toro AD, Alvarez R, Blazer KR, Yanez B, Ricker C, Unzeitig GW, et al. Abstract 2761: Evaluation of the BOADICEA model for predictingBRCA1andBRCA2mutation carrier probabilities in high-risk US Hispanic and Mexican families: A report from the Clinical Cancer Genetics Community Research Network Cancer Research. 75: 2761-2761. DOI: 10.1158/1538-7445.Am2015-2761  0.54
2013 Blazer KR, Espenschied C, Weissman B, Sand S, Weitzel JN. Next-generation sequencing for genetic cancer risk assessment: Critical needs and perceptions of community clinicians. Journal of Clinical Oncology. 31: 1536-1536. DOI: 10.1200/Jco.2013.31.15_Suppl.1536  0.483
2012 Macdonald DJ, Deri J, Ricker C, Perez MA, Ogaz R, Feldman N, Viveros LA, Paz B, Weitzel JN, Blazer KR. Closing the loop: an interactive action-research conference format for delivering updated medical information while eliciting Latina patient/family experiences and psychosocial needs post-genetic cancer risk assessment. Familial Cancer. 11: 449-58. PMID 22678665 DOI: 10.1007/S10689-012-9535-5  0.527
2012 Espenschied CR, MacDonald DJ, Culver JO, Sand S, Hurley K, Banks KC, Weitzel JN, Blazer KR. Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 27: 467-77. PMID 22610836 DOI: 10.1007/S13187-012-0373-9  0.459
2012 Beamer LC, Grant ML, Espenschied CR, Blazer KR, Hampel HL, Weitzel JN, MacDonald DJ. Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1058-63. PMID 22355048 DOI: 10.1200/Jco.2011.38.4719  0.436
2012 Blazer KR, Christie C, Uman G, Weitzel JN. Impact of web-based case conferencing on cancer genetics training outcomes for community-based clinicians. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 27: 217-25. PMID 22328115 DOI: 10.1007/S13187-012-0313-8  0.621
2012 Sand SR, Klifa C, Press MF, Pike M, Ursin G, Spicer D, Vora L, Daniels A, Blazer KR, Herzog J, Villalobos I, Weitzel JN. Abstract 3557: Reduced ovarian hormones & reduced mammographic & MRI determined breast density inBRCAcarriers following a hormonal chemo-prevention regimen of gonadotropin releasing hormone agonist (GnRHA) & low-dose add-back estrogen & testosterone: Cancer Research. 72: 3557-3557. DOI: 10.1158/1538-7445.Am2012-3557  0.411
2012 Villarreal-Garza C, Herrera L, Herzog J, Port D, Mohar A, Perez-Plasencia C, Clague J, Alvarez R, Santibanez M, Blazer K, Weitzel J. Abstract PD08-06: Significant Clinical impact of recurrentBRCA1andBRCA2(BRCA) mutations in Mexico Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Pd08-06  0.504
2011 Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit K. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine. Ca: a Cancer Journal For Clinicians. 61: 327-59. PMID 21858794 DOI: 10.3322/Caac.20128  0.511
2011 Blazer KR, Macdonald DJ, Culver JO, Huizenga CR, Morgan RJ, Uman GC, Weitzel JN. Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 13: 832-40. PMID 21629123 DOI: 10.1097/Gim.0B013E31821882B7  0.539
2011 Beamer LC, Grant M, MacDonald DJ, Hampel H, Blazer K, Huizenga C, Weitzel JN. Reflex microsatellite instability & immunohistochemistry testing practices & follow-up of abnormal results at U.S. cancer programs Hereditary Cancer in Clinical Practice. 9: P2. DOI: 10.1186/1897-4287-9-S1-P2  0.469
2011 Huizenga CR, Martir-Negron AE, Blazer KR, Culver JO, MacDonald DJ, Weitzel JN. Mind the gap: challenges in the clinical management of Lynch syndrome families Hereditary Cancer in Clinical Practice. 9: P16. DOI: 10.1186/1897-4287-9-S1-P16  0.457
2010 Blazer KR, Clague J, Collie CL, Ciadella-Kam LA, Kuratani DG, Laird SL, Sabado P, Warren KJ, Chang S. "Future directions in cancer prevention and control: workforce implications for training, practice, and policy" symposium, October 17 to 18, 2009, The University of Texas M. D. Anderson Cancer Center. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1655-60. PMID 20501765 DOI: 10.1158/1055-9965.Epi-10-0441  0.453
2010 MacDonald DJ, Blazer KR, Weitzel JN. Extending comprehensive cancer center expertise in clinical cancer genetics and genomics to diverse communities: the power of partnership. Journal of the National Comprehensive Cancer Network : Jnccn. 8: 615-24. PMID 20495088 DOI: 10.6004/Jnccn.2010.0046  0.508
2009 Klifa C, Sand S, Vora L, Press M, Orisamolu A, Pike M, Spicer D, Daniels A, Blazer K, Weitzel J. Magnetic Resonance Imaging quantification of breast density in BRCA carriers following gonadotropin releasing hormone agonist (GnRHA)-based hormonal chemoprevention. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1506. PMID 27964319 DOI: 10.1200/Jco.2009.27.15_Suppl.1506  0.378
2009 Pal SK, Blazer K, Weitzel J, Somlo G. An association between invasive breast cancer and familial idiopathic hyperparathyroidism: A case series and review of the literature Breast Cancer Research and Treatment. 115: 1-5. PMID 18500673 DOI: 10.1007/S10549-008-0056-8  0.496
2009 Deri J, Nuñez G, Ogaz R, Blazer K, Ricker C, Carbajal V, Weitzel J, MacDonald D. Honoramos A Todas Nuestras Madres Con El Don Del Conocimiento: A Conference To Learn the Needs of Latina Patients and Families Seen for Breast Cancer Risk Assessment. Cancer Research. 69: 3073-3073. DOI: 10.1158/0008-5472.Sabcs-09-3073  0.56
2008 Lowstuter KJ, Sand S, Blazer KR, MacDonald DJ, Banks KC, Lee CA, Schwerin BU, Juarez M, Uman GC, Weitzel JN. Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 10: 691-8. PMID 18978681 DOI: 10.1097/Gim.0B013E3181837246  0.466
2008 Lagos VI, Perez MA, Ricker CN, Blazer KR, Santiago NM, Feldman N, Viveros L, Weitzel JN. Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer. Psycho-Oncology. 17: 774-82. PMID 18646245 DOI: 10.1002/Pon.1358  0.519
2008 Jasperson KW, Blazer KR, Lowstuter K, Weitzel JN. Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation. Familial Cancer. 7: 281-5. PMID 18176851 DOI: 10.1007/S10689-007-9179-Z  0.459
2008 Lowstuter KJ, Sand S, Blazer KR. Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians (Genet Med 10, 691-698) Genetics in Medicine. 10: 762. DOI: 10.1097/01.gim.0000338565.96013.80  0.33
2007 Weitzel JN, Lagos VI, Herzog JS, Judkins T, Hendrickson B, Ho JS, Ricker CN, Lowstuter KJ, Blazer KR, Tomlinson G, Scholl T. Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1615-20. PMID 17646271 DOI: 10.1158/1055-9965.Epi-07-0198  0.371
2007 Weitzel JN, Lagos VI, Cullinane CA, Gambol PJ, Culver JO, Blazer KR, Palomares MR, Lowstuter KJ, MacDonald DJ. Limited family structure and BRCA gene mutation status in single cases of breast cancer. Jama. 297: 2587-95. PMID 17579227 DOI: 10.1001/Jama.297.23.2587  0.511
2007 Weitzel JN, Buys SS, Sherman WH, Daniels A, Ursin G, Daniels JR, MacDonald DJ, Blazer KR, Pike MC, Spicer DV. Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 654-8. PMID 17255289 DOI: 10.1158/1078-0432.Ccr-06-1902  0.343
2007 Ricker CN, Hiyama S, Fuentes S, Feldman N, Kumar V, Uman GC, Nedelcu R, Blazer KR, MacDonald DJ, Weitzel JN. Beliefs and interest in cancer risk in an underserved Latino cohort. Preventive Medicine. 44: 241-5. PMID 17027932 DOI: 10.1016/J.Ypmed.2006.08.018  0.533
2006 Blazer KR, MacDonald DJ, Justus KA, Grant M, Azen SP, Chamberlain RM, Petersen GM, King M, Weitzel JN. Creating tomorrow's leaders in cancer prevention: a novel interdisciplinary career development program in cancer genetics research. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 21: 216-22. PMID 17542713 DOI: 10.1080/08858190701347770  0.515
2006 Ricker C, Lagos V, Feldman N, Hiyama S, Fuentes S, Kumar V, Gonzalez K, Palomares M, Blazer K, Lowstuter K, MacDonald D, Weitzel J. If we build it ... will they come?--establishing a cancer genetics services clinic for an underserved predominantly Latina cohort. Journal of Genetic Counseling. 15: 505-14. PMID 17106633 DOI: 10.1007/S10897-006-9052-5  0.562
2006 Ho J, Herzog J, Lagos V, Lowstuter K, Palomares M, Blazer K, MacDonald D, Feldman N, Weitzel J. Characterization of a novel founder rearrangement mutation of BRCA1 in high-risk Hispanic families Journal of Clinical Oncology. 24: 10015-10015. DOI: 10.1200/Jco.2006.24.18_Suppl.10015  0.422
2006 MacDonald DJ, Sand S, Kass F, Blazer KR, Congleton J, Craig J, Weitzel JN. The Power of Partnership: Extending Comprehensive Cancer Center Expertise in Clinical Cancer Genetics to Community Breast Care Centers Seminars in Breast Disease. 9: 39-47. DOI: 10.1053/J.Sembd.2006.10.001  0.499
2005 Sand SR, DeRam DS, MacDonald DJ, Blazer KR, Weitzel JN. Linkage of a pedigree drawing program and database to a program for determining BRCA mutation carrier probability. Familial Cancer. 4: 313-6. PMID 16341809 DOI: 10.1007/S10689-005-8849-Y  0.314
2005 Weitzel JN, Lagos V, Blazer KR, Nelson R, Ricker C, Herzog J, McGuire C, Neuhausen S. Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1666-71. PMID 16030099 DOI: 10.1158/1055-9965.Epi-05-0072  0.497
2005 Blazer KR, MacDonald DJ, Ricker C, Sand S, Uman GC, Weitzel JN. Outcomes from intensive training in genetic cancer risk counseling for clinicians. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 7: 40-7. PMID 15654227 DOI: 10.1097/01.Gim.0000151154.27612.49  0.524
2004 Bahadini B, Herzog J, Somlo G, Frankel P, Sand S, MacDonald D, Blazer K, Weitzel JN. Prevalence of BRCA mutations in a cohort of young high-risk breast cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 9662. PMID 28016293 DOI: 10.1200/jco.2004.22.14_suppl.9662  0.408
2004 Nedelcu R, Blazer KR, Schwerin BU, Gambol P, Mantha P, Uman GC, Weitzel JN. Genetic discrimination: The clinician perspective Clinical Genetics. 66: 311-317. PMID 15355433 DOI: 10.1111/J.1399-0004.2004.00303.X  0.438
2004 Blazer KR, Grant M, Sand SR, MacDonald DJ, Uman GC, Weitzel JN. Effects of a cancer genetics education programme on clinician knowledge and practice Journal of Medical Genetics. 41: 518-522. PMID 15235022 DOI: 10.1136/Jmg.2004.018234  0.539
2004 Bahadini B, Herzog J, Somlo G, Frankel P, Sand S, MacDonald D, Blazer K, Weitzel JN. Prevalence of BRCA mutations in a cohort of young high-risk breast cancer patients Journal of Clinical Oncology. 22: 9662-9662. DOI: 10.1200/Jco.2004.22.90140.9662  0.512
2003 Weitzel JN, McCaffrey SM, Nedelcu R, MacDonald DJ, Blazer KR, Cullinane CA. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Archives of Surgery (Chicago, Ill. : 1960). 138: 1323-8; discussion 1. PMID 14662532 DOI: 10.1001/Archsurg.138.12.1323  0.596
2003 Loo JCY, Liu L, Hao A, Gao L, Agatep R, Shennan M, Summers A, Goldstein AM, Tucker MA, Deters C, Fusaro R, Blazer K, Weitzel J, Lassam N, Lynch H, et al. Germline splicing mutations of CDKN2A predispose to melanoma Oncogene. 22: 6387-6394. PMID 14508519 DOI: 10.1038/Sj.Onc.1206736  0.344
2002 MacDonald DJ, Choi J, Ferrell B, Sand S, McCaffrey S, Blazer KR, Grant M, Weitzel JN. Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment [9] Journal of Medical Genetics. 39: 526-530. PMID 12114489 DOI: 10.1136/Jmg.39.7.526  0.588
2002 Blazer KR, Grant M, Sand SR, MacDonald DJ, Choi JJ, Nedelcu RA, Weitzel JN. Development of a cancer genetics education program for clinicians. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 17: 69-73. PMID 12092855 DOI: 10.1080/08858190209528801  0.425
2001 Weitzel JN, Choi J, Blazer KR, McCahill LE, Nedelcu RA, McCaffrey S, MacDonald DJ. Impact of genetic risk assessment in newly-diagnosed breast cancer management Breast Cancer Research and Treatment. 69: 224.  0.461
Show low-probability matches.